Inventory Optimization In Full Focus in the Turbulent Economy
If you follow the stock market, you might think the economy is strong. As consumers, we are frustrated with the price of everyday supplies such as food, gas, and housing.
If you follow the stock market, you might think the economy is strong. As consumers, we are frustrated with the price of everyday supplies such as food, gas, and housing.
Volatility, uncertainty, complexity, and ambiguity (VUCA) continues to rage and threaten manufacturers and supply chain chain organizations. The VUCA threshold skyrocketed during the pandemic, and it has not returned to normal.
How can manufacturers prepare for sudden demand surges and unexpected market shifts? In this From the Ground Up podcast discussion, Lisa Anderson shares strategies for building flexible, resilient supply chains that can respond quickly to demand shocks and support profitable growth.
Lisa Anderson, a supply chain expert and consultant who founded LMA Consulting Group, says projecting future demand is paramount when facing a demand surge.
According to the ISM, "The Manufacturing PMI", a measure of manufacturing activity, registered at 48.5% in June, which is a decline from 48.7% in May.
The world faces economic headwinds. According to the Economist, Europe’s economy only grew at 4% this decade as compared with 8% of the United States and is struggling with a triple shock of the energy crisis, surging Chinese imports, and the threat of tariffs from the United States.
There is substantial geopolitical risk with China. Look no further than the South China Seas. Philippine officials say Chinese forces seized two naval boats in a disputed South China Sea shoal. A few days prior, a Philippine ship and a Chinese vessel collided. It is a risky situation in the South China Seas.
Escalating conflict in the Red Sea has exposed the vulnerability of global pharmaceutical supply chains and reinforced the importance of building more resilient sourcing and logistics strategies. In this interview, Lisa Anderson discusses how Houthi attacks on commercial shipping are increasing transportation costs, extending transit times, and prompting pharmaceutical [...]
The medical device market is expected to grow by almost $178 billion from 2023 to 2027 according to Technavio. Moreover, a Fortune Business Insights Analysis estimates the market to reach $799 billion by 2030. With such significant growth, manufacturing and supply chains must scale and mitigate risk to ensure supplies to customers and patients.
As Mexico ushers in its first female president, Claudia Sheinbaum Pardo, and reaffirms its commitment to the "fourth transformation," Lisa Anderson, MBA, CSCP, CLTD, President of LMA Consulting Group Inc., shares her insights on how this political shift is expected to enhance nearshoring opportunities for U.S. manufacturers.